SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-036729
Filing Date
2020-08-05
Accepted
2020-08-05 15:27:56
Documents
76
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q akca-10q_20200630.htm   iXBRL 10-Q 3360500
2 EX-31.1 akca-ex311_6.htm EX-31.1 18967
3 EX-31.2 akca-ex312_7.htm EX-31.2 18984
4 EX-32.1 akca-ex321_8.htm EX-32.1 10838
  Complete submission text file 0001564590-20-036729.txt   11422307

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA akca-20200630.xsd EX-101.SCH 69813
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akca-20200630_cal.xml EX-101.CAL 62234
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akca-20200630_def.xml EX-101.DEF 251087
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE akca-20200630_lab.xml EX-101.LAB 461118
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akca-20200630_pre.xml EX-101.PRE 372342
10 EXTRACTED XBRL INSTANCE DOCUMENT akca-10q_20200630_htm.xml XML 2474348
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38137 | Film No.: 201076943
SIC: 2834 Pharmaceutical Preparations